Impact of I-Corps: A 10-Year Retrospective 

Impact of I-Corps: A 10-Year Retrospective 

August 5 (Thursday) 
12:00 – 1:00 PM EDT 
Presenters: 
Rathindra (Babu) DasGupta, PhD – University of Wisconsin-Milwaukee 
Errol Arkilic, PhD – M34 Capital 
Christie A. Canaria, PhD – National Cancer Institute

$150 Members/$225 Non-Members 
Join us as we look back on the impact the I-Corps customary discovery methodology has had on the commercialization of university research. Participants will have the chance to learn from three I-Corps Program Directors who will share their personal observations and perspectives while addressing the impact of I-Corps in the last 10 years. 

I-Corps applicants and administrators alike will benefit from attending this session. I-Corps applicants will learn how to prepare competitive proposals, understand what makes a good commercialization team and discover what universities can do to make their programs, and their startup teams, stronger. Administrators will learn how they can successfully run sites through a discussion of what techniques have worked well, what things haven’t worked as expected, and what lessons the directors have taken away pre- and post-COVID. 

This session will begin with a presentation on the genesis of I-Corps by looking at the founding principles that led to the formation of the NSF program. Next, participants will hear about the cooperative, interagency partnership that led to the start of the I-Corps at NIH Program. Through success stories and real life-clinical impacts, you’ll discover the lasting effects of this program and understand the differences between the NSF and NIH curriculum. Finally, participants will hear the university perspective of leveraging the program. Hear the impact of entrepreneurship training and success factors for academic spinoffs and how I-Corps can be applied in other areas. 

Learning Objectives: 
  • Understand the difference between the I-Corps at NSF and I-Corps at NIH curriculums. 
  • Prepare stronger I-Corps proposals and more competitive NSF proposals. 
  • Describe the impact the program has had on faculty, universities, and spinouts. 
  • Explain what makes a good commercialization team
  • Describe what techniques have worked well and where there is room for future enhancement.